What is Northland Capmk’s Estimate for Arteris Q1 Earnings?

Arteris, Inc. (NASDAQ:AIP) – Analysts at Northland Capmk issued their Q1 2026 earnings estimates for shares of Arteris in a note issued to investors on Wednesday, February 19th. Northland Capmk analyst G. Richard anticipates that the company will post earnings per share of ($0.14) for the quarter. The consensus estimate for Arteris’ current full-year earnings is ($0.71) per share. Northland Capmk also issued estimates for Arteris’ Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.10) EPS and Q4 2026 earnings at ($0.07) EPS.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The business had revenue of $15.49 million for the quarter, compared to the consensus estimate of $15.34 million. Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%.

AIP has been the subject of several other reports. Northland Securities raised their target price on shares of Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Wednesday. Rosenblatt Securities reissued a “buy” rating and issued a $15.00 target price on shares of Arteris in a research note on Tuesday.

Arteris Price Performance

Shares of AIP opened at $9.28 on Friday. Arteris has a twelve month low of $5.76 and a twelve month high of $12.64. The company has a quick ratio of 1.16, a current ratio of 1.17 and a debt-to-equity ratio of 0.30. The company has a 50 day moving average of $10.53 and a 200-day moving average of $8.72. The stock has a market capitalization of $380.02 million, a P/E ratio of -10.67 and a beta of 1.18.

Insider Activity at Arteris

In other Arteris news, Director Saiyed Atiq Raza sold 2,776 shares of Arteris stock in a transaction on Monday, January 6th. The shares were sold at an average price of $12.34, for a total transaction of $34,255.84. Following the completion of the transaction, the director now directly owns 684,320 shares of the company’s stock, valued at $8,444,508.80. The trade was a 0.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Paul L. Alpern sold 3,326 shares of Arteris stock in a transaction on Monday, January 6th. The stock was sold at an average price of $12.35, for a total value of $41,076.10. Following the sale, the vice president now directly owns 61,604 shares of the company’s stock, valued at $760,809.40. This represents a 5.12 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 367,157 shares of company stock valued at $3,828,388. 33.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of AIP. US Bancorp DE acquired a new stake in shares of Arteris during the third quarter worth $34,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Arteris during the third quarter worth $226,000. MetLife Investment Management LLC lifted its holdings in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Arteris by 36.3% during the third quarter. Jacobs Levy Equity Management Inc. now owns 253,211 shares of the company’s stock worth $1,955,000 after buying an additional 67,414 shares in the last quarter. Finally, Needham Investment Management LLC lifted its holdings in shares of Arteris by 14.7% during the third quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company’s stock worth $21,114,000 after buying an additional 350,000 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.